livanova plc is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.at livanova, we understand the importance of bringing both clinical and economic value to our customers. we are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. livanova is listed on the nasdaq stock exchange under the ticker symbol “livn.” livanova has approximately 3,000 employees worldwide. we are headquartered in london (uk) and maintain a presence in more than 100 countries. livanova is a worldwide leader in advanced circulatory support, cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.
Company profile
Ticker
LIVN
Exchange
Website
CEO
Damien McDonald
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • BioPlus Acquisition • QT Imaging • Outset Medical • Fonar ...
Former names
Sand Holdco Plc
SEC CIK
Corporate docs
Subsidiaries
Caisson Interventional, LLC • CardiacAssist, Inc. • Cyberonics Holdings, LLC • ALung Technologies, Inc. • ImThera Medical, Inc. • LivaNova Australia PTY Limited • LivaNova Austria GmbH • LivaNova Belgium N.V. • LivaNova Brasil Comércio e Distribuição de Equipamentos Médico-hospitalares Ltda • LivaNova Canada, Inc. ...
LIVN stock data
Latest filings (excl ownership)
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3 May 24
10-Q
2024 Q1
Quarterly report
3 May 24
8-K
LivaNova Reports First-Quarter 2024 Results
1 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Entry into a Material Definitive Agreement
8 Mar 24
8-K
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
5 Mar 24
8-K
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
4 Mar 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
29 Feb 24
Transcripts
LIVN
Earnings call transcript
2024 Q1
1 May 24
LIVN
Earnings call transcript
2023 Q4
21 Feb 24
LIVN
Earnings call transcript
2023 Q3
1 Nov 23
LIVN
Earnings call transcript
2023 Q2
26 Jul 23
LIVN
Earnings call transcript
2023 Q2
26 Jul 23
LIVN
Earnings call transcript
2023 Q1
3 May 23
LIVN
Earnings call transcript
2022 Q4
22 Feb 23
LIVN
Earnings call transcript
2022 Q3
2 Nov 22
LIVN
Earnings call transcript
2022 Q2
7 Aug 22
LIVN
Earnings call transcript
2022 Q1
8 May 22
Latest ownership filings
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
17 Apr 24
4
Stephanie Bolton
2 Apr 24
4
WILLIAM A KOZY
2 Apr 24
4
Trui Hebbelinck
2 Apr 24
4
Vladimir Makatsaria
2 Apr 24
4
Alex Shvartsburg
2 Apr 24
4
Michael Damon Hutchinson
2 Apr 24
3
Stephanie Bolton
11 Mar 24
3
Vladimir Makatsaria
4 Mar 24
4
WILLIAM A KOZY
4 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 532.72 mm | 532.72 mm | 532.72 mm | 532.72 mm | 532.72 mm | 532.72 mm |
Cash burn (monthly) | 546.00 k | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 3.96 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 528.76 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 968.4 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2023
2.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 27 |
Opened positions | 5 |
Closed positions | 189 |
Increased positions | 4 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 49.28 bn |
Total shares | 1.10 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Allspring Global Investments | 829.58 k | $42.92 bn |
New York State Teachers Retirement System | 64.12 k | $3.32 mm |
SG Americas Securities | 37.61 k | $1.95 mm |
Mutual Of America Capital Management | 33.30 k | $1.72 bn |
DekaBank Deutsche Girozentrale | 31.90 k | $1.65 mm |
Mirae Asset Global Investments | 28.98 k | $1.50 bn |
Arizona State Retirement System | 15.06 k | $779.36 mm |
State Of Michigan Retirement System | 12.91 k | $668.02 mm |
Diversified Trust | 12.09 k | $625.74 mm |
New Mexico Educational Retirement Board | 10.90 k | $564.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Mar 24 | Stephanie Bolton | Ordinary Shares | Payment of exercise | Dispose F | No | No | 55.94 | 3,643 | 203.79 k | 9,562 |
30 Mar 24 | Stephanie Bolton | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 7,744 | 0.00 | 13,205 |
30 Mar 24 | Stephanie Bolton | Stock Appreciation Rights Ordinary Shares | Grant | Acquire A | No | No | 55.94 | 10,746 | 601.13 k | 10,746 |
30 Mar 24 | Stephanie Bolton | Performance Stock Units Ordinary Shares | Grant | Acquire A | No | No | 0 | 4,915 | 0.00 | 4,915 |
30 Mar 24 | Stephanie Bolton | Performance Stock Units Ordinary Shares | Grant | Acquire A | No | No | 0 | 2,457 | 0.00 | 2,457 |
30 Mar 24 | Stephanie Bolton | Performance Stock Units Ordinary Shares | Grant | Acquire A | No | No | 0 | 2,457 | 0.00 | 2,457 |
30 Mar 24 | Stephanie Bolton | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 4,915 | 0.00 | 4,915 |
30 Mar 24 | Stephanie Bolton | Performance Stock Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 1,961 | 0.00 | 0 |
30 Mar 24 | Stephanie Bolton | Performance Stock Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 1,290 | 0.00 | 0 |
30 Mar 24 | Stephanie Bolton | Performance Stock Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 1,706 | 0.00 | 0 |
News
Mizuho Maintains Buy on LivaNova, Raises Price Target to $80
2 May 24
Baird Maintains Neutral on LivaNova, Raises Price Target to $66
2 May 24
Needham Reiterates Buy on LivaNova, Maintains $72 Price Target
1 May 24
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
1 May 24
LivaNova Raises FY24 Adjusted EPS In The Range Of $3.05-$3.15 Vs. $3 Estimate (Prior View: $2.95-$3.05); Expects Revenue To Grow Between 8%-9% On Constant-currency Basis (Prior View: 4%-5%)
1 May 24
Press releases
LivaNova Reports First-Quarter 2024 Results
1 May 24
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
30 Apr 24
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
25 Apr 24
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029 | LIVN Stock News
5 Mar 24
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
5 Mar 24